BioWorld Science

RSS

FDA clears IND for phase I study of LB-1901 in relapsed or refractory T-cell lymphoma

Dec. 15, 2020

Arvinas reports interim clinical data for ARV-471 and ARV-110

Dec. 15, 2020

First patient dosed in phase II BLUEPRINT study of BLU-5937

Dec. 15, 2020

Nuclear receptors protect against kidney disease

Dec. 15, 2020

AB-729 results in robust reduction in HBsAg in patients with chronic hepatitis B

Dec. 15, 2020

ADU-S100 plus pembrolizumab appears well tolerated in recurrent/metastatic HNSCC

Dec. 15, 2020

TCR2 presents positive interim data from ongoing phase I/II study of gavo-cel

Dec. 15, 2020

CureVac initiates pivotal phase IIb/III study of CVnCoV

Dec. 15, 2020

Missense variants in c-Myc, CDK4 and ARHGDIA genes identified as potential causes of MODY by WES

Dec. 15, 2020

Aravive opens enrollment in phase Ib/II study of AVB-S6-500 in clear cell renal cell carcinoma

Dec. 15, 2020